drugset / Trial / NCT07300189
A Study to Evaluate Single and Multiple Doses of TLC-1180 in Healthy Subjects
RandomizedSequentialDouble-blindTreatment
Summary
This phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of TLC-1180 after single- and multiple-ascending doses in healthy subjects.
Timeline
- Start
- 2025-10-20
- Primary completion
- 2027-04-01
- Completion
- 2027-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TLC-1180 | Unknown | — | Oral |
Indications
No indication recorded.